Permanent pacemaker implantation is never a benign complication after aortic valve replacement

Since the first report of an in-man transcatheter aortic valve replacement (TAVR) in 2002 by Cribier et al. (1), its role in the management of severe aortic stenosis (AS) has grown rapidly.